Phase I study of cancer therapy with recombinant interleukin-2 administered by intravenous bolus injection

Evan M. Hersh, J. Lee Murray, Waun Ki Hong, Michael G. Rosenblum, James M. Reuben, Robert Weilbaecher, Amar N. Sarwal, Edward C. Bradley, Michael Konrad, Frank C. Arnett

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I study of cancer therapy with recombinant interleukin-2 administered by intravenous bolus injection'. Together they form a unique fingerprint.

Medicine & Life Sciences